Literature DB >> 11867271

Antiestrogenic activities of Cimicifuga racemosa extracts.

Oliver Zierau1, Claudia Bodinet, Susanne Kolba, Marina Wulf, Günter Vollmer.   

Abstract

Despite the wide use of extracts from the rhizome of black cohosh (Cimicifuga racemosa) for the treatment of menopausal complaints, surprisingly little is known on their potential estrogenic properties, e.g. on estrogen dependent gene transcription. In addition, available informations on the effects on cell proliferation are contradictory. We therefore, tested for estrogenic and antiestrogenic effects of Cimicifuga racemosa extracts on proliferation of MCF-7 cells and on gene expression using ethanolic and iso-propanolic extracts of this medical plant. Estrogenic properties of plant extracts could neither be detected in proliferation assays, nor on gene expression using an estradiol-inducible yeast assay or the estrogen-inducible MVLN cells. In contrast, in all three experimental systems Cimicifuga racemosa antagonized estradiol induced activities. Estradiol induced stimulation of proliferation was inhibited by a dosage >1 microg/ml of extract concentration, gene expression was suppressed by doses of 100-1000 microg/ml of Cimicifuga racemosa extracts. From these results we conclude, that extracts from the rhizome of Cimicifuga racemosa contain compounds with antiestrogenic properties.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867271     DOI: 10.1016/s0960-0760(01)00178-9

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  10 in total

Review 1.  Botanical and dietary supplements for menopausal symptoms: what works, what does not.

Authors:  Stacie E Geller; Laura Studee
Journal:  J Womens Health (Larchmt)       Date:  2005-09       Impact factor: 2.681

Review 2.  Contemporary alternatives to plant estrogens for menopause.

Authors:  Stacie E Geller; Laura Studee
Journal:  Maturitas       Date:  2006-08-01       Impact factor: 4.342

Review 3.  Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings.

Authors:  Susan Arentz; Jason Anthony Abbott; Caroline Anne Smith; Alan Bensoussan
Journal:  BMC Complement Altern Med       Date:  2014-12-18       Impact factor: 3.659

4.  Phytochemistry of cimicifugic acids and associated bases in Cimicifuga racemosa root extracts.

Authors:  Tanja Gödecke; Dejan Nikolic; David C Lankin; Shao-Nong Chen; Sharla L Powell; Birgit Dietz; Judy L Bolton; Richard B van Breemen; Norman R Farnsworth; Guido F Pauli
Journal:  Phytochem Anal       Date:  2009 Mar-Apr       Impact factor: 3.373

Review 5.  Botanical modulation of menopausal symptoms: mechanisms of action?

Authors:  Atieh Hajirahimkhan; Birgit M Dietz; Judy L Bolton
Journal:  Planta Med       Date:  2013-02-13       Impact factor: 3.352

Review 6.  Black cohosh (Cimicifuga racemosa [L.] Nutt.): safety and efficacy for cancer patients.

Authors:  Rishma Walji; Heather Boon; Emma Guns; Doreen Oneschuk; Jawaid Younus
Journal:  Support Care Cancer       Date:  2007-06-30       Impact factor: 3.603

7.  Black Cohosh: Insights into its Mechanism(s) of Action.

Authors:  Rachel L Ruhlen; Grace Y Sun; Edward R Sauter
Journal:  Integr Med Insights       Date:  2008-08-27

8.  Physiological Concentrations of Cimicifuga racemosa Extract Do Not Affect Expression of Genes Involved in Estrogen Biosynthesis and Action in Endometrial and Ovarian Cell Lines.

Authors:  Maša Sinreih; Klara Gregorič; Kristina Gajser; Tea Lanišnik Rižner
Journal:  Biomolecules       Date:  2022-04-05

9.  Gene expression profiling reveals effects of Cimicifuga racemosa (L.) NUTT. (black cohosh) on the estrogen receptor positive human breast cancer cell line MCF-7.

Authors:  Friedemann Gaube; Stefan Wolfl; Larissa Pusch; Torsten C Kroll; Matthias Hamburger
Journal:  BMC Pharmacol       Date:  2007-09-20

10.  A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients.

Authors:  Juergen Drewe; Kathleen A Bucher; Catherine Zahner
Journal:  Springerplus       Date:  2015-02-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.